EMA Authorised: Sunosi (solriamfetol hydrochloride) — Atnahs Pharma Netherlands B.V.

View source ↗

Summary

Sunosi (solriamfetol hydrochloride) has been authorised in the European Union for the treatment of narcolepsy and obstructive sleep apnea; decision dated 2025-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea

Drugs mentioned

• Sunosi (solriamfetol)

Snippet

Status: Authorised. Therapeutic area: Narcolepsy;Sleep Apnea, Obstructive. MAH: Atnahs Pharma Netherlands B.V.. Decision date: 10/07/2025